Biote Corp. BTMD

Institutional shares held 18.3 Million

0 calls

0 puts

Total value of holdings $64.6M

$0 calls

$0 puts

Market Cap $26.8M

7,574,270 Shares Out.

Institutional ownership 241.09%

# of Institutions 88

We take great care to ensure that the data presented and summarized in this overview for biote Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.

Quarterly Institutional Activity in BTMD

Shares Bought

Shares Sold

View Transactions

Top Institutions Holding BTMD

View all

Latest Institutional Activity in BTMD

Top Purchases

Q1 2025

Sg Americas Securities, LLC Shares Held: 19.2K ($67.9K)

6.96K Shares purchased

56.84% Added

Q1 2025

Cwm, LLC Shares Held: 824 ($2.92K)

678 Shares purchased

464.38% Added

Q1 2025

Amalgamated Bank Shares Held: 929 ($3.29K)

457 Shares purchased

96.82% Added

Q1 2025

Nisa Investment Advisors, LLC Shares Held: 330 ($1.17K)

193 Shares purchased

140.88% Added

Q1 2025

Sbi Securities Co., Ltd. Shares Held: 33 ($117)

1 Shares purchased

3.13% Added

View All Buyers

Top Sells

Q1 2025

Sanders Morris Harris LLC Shares Held: 49.9K ($177K)

5.2K Shares sold

9.44% Reduced

Q1 2025

Rhumbline Advisers Shares Held: 36.3K ($128K)

1.42K Shares sold

3.78% Reduced

Q1 2025

Skylands Capital, LLC Shares Held: 159K ($561K)

900 Shares sold

0.56% Reduced

Q4 2024

Sw Investment Management LLC Shares Held: 300K ($1.06M)

200K Shares sold

40.0% Reduced

Q4 2024

Two Sigma Investments, LP Shares Held: 49.3K ($175K)

40.7K Shares sold

45.24% Reduced

View All Sellers

About BTMD

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Insider Transactions at BTMD

Insider Transaction List

View all

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Apr 30 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	1,933 +0.05%	$5,799 $3.3 P/Share
Apr 21 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	8,801 +0.21%	$26,403 $3.27 P/Share
Apr 17 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	6,874 +0.16%	$20,622 $3.29 P/Share
Apr 16 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	1,000 +0.02%	$3,000 $3.29 P/Share
Apr 09 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	13,532 +0.32%	$40,596 $3.21 P/Share
Apr 08 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	34,907 +0.84%	$104,721 $3.21 P/Share
Apr 07 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	43,378 +1.04%	$130,134 $3.15 P/Share
Apr 04 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	23,741 +0.58%	$71,223 $3.24 P/Share
Apr 03 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	7,321 +0.18%	$21,963 $3.24 P/Share
Mar 31 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	106,000 +2.56%	$318,000 $3.32 P/Share
Mar 17 2025	Andrew R Heyer	BUY Open market or private purchase	Indirect	25,000 +6.33%	$75,000 $3.95 P/Share
Mar 17 2025	Andrew R Heyer	BUY Open market or private purchase	Direct	50,000 +3.18%	$150,000 $3.95 P/Share
Mar 17 2025	Stephen Mark Cone	BUY Open market or private purchase	Direct	38,104 +19.15%	$114,312 $3.88 P/Share
Mar 17 2025	Bret Christensen Chief Executive Officer	BUY Open market or private purchase	Direct	37,595 +50.0%	$112,785 $3.87 P/Share
Mar 17 2025	Marc D Beer Executive Chairman	BUY Open market or private purchase	Direct	107,794 +50.0%	$323,382 $3.87 P/Share
Mar 17 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	100 +0.0%	$300 $3.74 P/Share
Mar 14 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	106,509 +2.64%	$319,527 $3.5 P/Share
Mar 13 2025	Guines LLC > 10% Shareholder	BUY Open market or private purchase	Indirect	750,000 +16.41%	$2,250,000 $3.22 P/Share
Sep 09 2024	Robert Charles Peterson Chief Financial Officer	SELL Open market or private sale	Direct	32,874 -100.0%	$197,244 $6.2 P/Share
Jul 09 2024	Robert Charles Peterson Chief Financial Officer	SELL Open market or private sale	Direct	11,376 -25.71%	$79,632 $7.57 P/Share

View All Transactions

Last 12 Months Summary

Buy / Acquisition

1.43M Shares

From 8 Insiders

Open market or private purchase	1.36M shares
Exercise of conversion of derivative security	65K shares

Sell / Disposition

44.3K Shares

From 1 Insiders

Open market or private sale	44.3K shares

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTMD shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Biote Corp. insider buys or sells BTMD shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to biote Corp.

Track Activities on BTMD

Account

Biote Corp. BTMD

Quarterly Institutional Activity in BTMD

Top Institutions Holding BTMD

Latest Institutional Activity in BTMD

Top Purchases

Top Sells

About BTMD

Insider Transactions at BTMD

Insider Transaction List

Last 12 Months Summary

Track Institutional and Insider Activities on BTMD

Institutional Portfolio Updates

Insider Trading

News